The Joint British Diabetes Societies for Inpatient Care (JBDS-IP) have launched new audit on the use of variable-rate intravenous insulin infusions (VRIIIs). Healthcare professionals including Diabetes Specialist Nurses are being asked to complete a questionnaire on how they used VRIIIs on people with diabetes who were admitted to hospital.
The JBDS-IP will use the feedback to update its VRIII guideline, which dates back to October 2014 and aims to guide non-specialist teams in the appropriate and safe use of a VRIII.
The audit is open until Friday 24th December 2021. Note that patients in whom VRIII was started due to diabetic ketoacidosis, hyperosmolar hyperglycaemic state or COVID-19 infection should not be included.
Click here to complete the audit.